Avalon GloboCare (ALBT) had the highest return between August 1, 2017 and March 31, 2018 by a US stock, returning 3,651,415.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | 8/1/2017 - 3/31/2018 | 3,651,415.15% |
GT Biopharma (GTBP) | 8/1/2017 - 3/31/2018 | 3,478,828.57% |
Delcath Systems (DCTH) | 8/1/2017 - 3/31/2018 | 8,158.88% |
Quantum Computing (QUBT) | 8/1/2017 - 3/31/2018 | 5,900% |
SurgePays (SURG) | 8/1/2017 - 3/31/2018 | 4,537.68% |
American Resources Corp Class A (AREC) | 8/1/2017 - 3/31/2018 | 1,270% |
TON Strategy (TONX) | 8/1/2017 - 3/31/2018 | 1,108.33% |
Madrigal Pharmaceuticals (MDGL) | 8/1/2017 - 3/31/2018 | 653.48% |
Gyre Therapeutics (GYRE) | 8/1/2017 - 3/31/2018 | 529.27% |
CareDx (CDNA) | 8/1/2017 - 3/31/2018 | 490.37% |
Avalo Therapeutics (AVTX) | 8/1/2017 - 3/31/2018 | 472% |
VerifyMe (VRME) | 8/1/2017 - 3/31/2018 | 459.12% |
Gravity (GRVY) | 8/1/2017 - 3/31/2018 | 457.34% |
Nixxy (NIXX) | 8/1/2017 - 3/31/2018 | 445.45% |
Galaxy Digital (GLXY) | 8/1/2017 - 3/31/2018 | 426.38% |
Rocket Pharmaceuticals (RCKT) | 8/1/2017 - 3/31/2018 | 417.96% |
Enphase Energy (ENPH) | 8/1/2017 - 3/31/2018 | 391.4% |
Zynex (ZYXI) | 8/1/2017 - 3/31/2018 | 384.22% |
Nektar Therapeutics (NKTR) | 8/1/2017 - 3/31/2018 | 383% |
Anixa Biosciences (ANIX) | 8/1/2017 - 3/31/2018 | 380% |
CIMG (IMG) | 8/1/2017 - 3/31/2018 | 340.74% |
eGain (EGAN) | 8/1/2017 - 3/31/2018 | 329.73% |
AnaptysBio (ANAB) | 8/1/2017 - 3/31/2018 | 326.38% |
Viking Therapeutics (VKTX) | 8/1/2017 - 3/31/2018 | 324.27% |
InMed Pharmaceuticals (INM) | 8/1/2017 - 3/31/2018 | 317.86% |
